Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancer

Otolaryngol Pol. 2000;54(3):291-5.
No abstract available

MeSH terms

  • Disease Progression
  • Genes, Tumor Suppressor / genetics
  • Genes, p16 / genetics*
  • Head and Neck Neoplasms / enzymology*
  • Head and Neck Neoplasms / genetics*
  • Humans
  • Prognosis
  • Telomerase / genetics*
  • Telomerase / metabolism*

Substances

  • Telomerase